Vincerx Pharma, Inc. - Common Stock (VINC) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q1 2025

Type / Class
Equity / Common Stock
Symbol
VINC on Nasdaq
Price per share
$0.10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vincerx Pharma, Inc. - Common Stock (VINC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SAGE RHINO CAPITAL LLC 0% $426 4,260 Sage Rhino Capital, LLC 29 Jan 2025

Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$1,260,341 $0.10 0
2024 Q4 4,798,188 $1,260,341 -$3,365,473 $0.26 20
2024 Q3 11,016,724 $7,888,820 +$210,405 $0.72 26
2024 Q2 10,694,186 $8,661,370 -$5,375,704 $0.81 26
2024 Q1 8,446,457 $42,738,472 -$714,541 $5.06 35
2023 Q4 9,796,408 $11,559,813 -$1,040,974 $1.18 31
2023 Q3 10,703,397 $10,822,316 -$1,891,253 $1.01 35
2023 Q2 12,071,205 $15,690,450 -$937,495 $1.30 34
2023 Q1 12,819,603 $13,332,261 +$58,354 $1.04 35
2022 Q4 12,763,782 $13,017,233 -$2,523,570 $1.02 34
2022 Q3 14,525,788 $20,043,824 +$814,332 $1.38 41
2022 Q2 13,944,353 $18,410,000 -$8,562,871 $1.32 44
2022 Q1 16,279,025 $65,122,000 -$3,570,679 $4.00 65
2021 Q4 15,391,072 $156,763,000 -$9,725,600 $10.19 55
2021 Q3 15,435,572 $248,886,000 +$55,421,873 $16.17 55
2021 Q2 12,116,423 $157,285,000 +$36,210,346 $12.99 55
2021 Q1 8,861,488 $171,025,000 +$96,062,128 $19.30 36
2020 Q4 3,803,775 $79,536,000 +$67,969,000 $20.91 18